Related Experiment Video
Updated: Jun 7, 2025
09:41
Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
13.3K
Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn's Disease
Jiejie Zhu1,2, Nannan Zhu1,2, Jiren Wang1,2
1Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Gastroenterology Research and Practice
|November 11, 2024
Summary
Monocyte CD36 expression is altered in Crohn's disease (CD), with decreased levels correlating to disease activity. This suggests CD36 may serve as a biomarker for assessing CD progression.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Crohn's disease (CD) is a chronic inflammatory condition with complex etiology.
- Cluster of differentiation 36 (CD36) is implicated in inflammation and metabolic diseases, but its role in CD remains undefined.
Purpose of the Study:
- To investigate the role of CD36 in monocytes of patients with Crohn's disease.
- To determine if CD36 expression correlates with disease activity in CD.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) were isolated from CD patients and healthy controls.
- Flow cytometry was used to analyze CD14+CD36+ monocyte subsets and CD36 expression on monocytes.
Main Results:
- The frequency of CD14+CD36+ monocytes was elevated in active CD patients compared to those in remission and healthy controls.
- CD36 expression on monocytes was decreased in active CD patients and negatively correlated with disease activity markers (HBI, SES-CD, CRP, NLR).
Conclusions:
- Monocyte CD36 expression is associated with disease activity in Crohn's disease.
- CD36 may represent a potential biomarker for assessing CD activity.
